Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00390221
Brief Title: Safety and Efficacy Study of Daclizumab High Yield Process (DAC HYP) to Treat Relapsing-Remitting Multiple Sclerosis (SELECT)

First Submitted : October 17, 2006
First Submitted that Met QC Criteria : October 18, 2006
First Posted : October 19, 2006 (Estimate)

Results First Submitted : May 31, 2016
Results First Submitted that Met QC Criteria : May 31, 2016
Results First Posted : July 11, 2016 (Estimate)

Certification/Extension First Submitted : October 13, 2014
Certification/Extension First Submitted that Met QC Criteria : October 13, 2014
Certification/Extension First Posted : October 22, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : May 31, 2016
Last Update Posted : July 11, 2016 (Estimate)